Covance Laboratories Ltd.: a Contract Development Organisation providing all essential biotechnology development services to support product development at biopharmaceutical customers
Visit the company website www.covance.com/biotech for full information.
Covance is an independent, publicly held company with over 6,500 staff operating in 17 countries and 30 offices world-wide. Covance is the only Contract Development Organisation that can deliver to its biopharmaceutical customers all of the essential biotechnology development services required to support product development to proof of principle and beyond. We have over 14 years experience in providing biotechnology product support. Services include GMP cell banking; GLP cell bank qualification, including viral and microbial safety; purification process scale-down validation and evaluation for viral clearance; GMP protein chemistry analysis for product characterisation, batch release and stability. Vector fate bio-distribution studies for gene therapy and biopotency assay development are also specialities. All pre-clinical and clinical needs are also catered for. All non-clinical services are available at one site in Harrogate, Yorkshire in the UK. Studies are subject to inspections by the UK MHRA, as well as the FDA. Regular inspections by the QA departments of client companies are also encouraged. Our experts provide scientific and regulatory advice for small and large programmes of work for submission to regulatory authorities world-wide.
More information can be found at www.covance.com/biotech